The level of LAG-3 expression on the Tregs was coincident with impairment of LMP1/2-specific T-cell function [130] suggesting a pivotal role for LAG-3+ regulatory T cells in the suppression of EBV specific cytotoxic CD8+ cell-mediated immunity in HL [130]. The gene discussed is CD8A; the disease is Hodgkins lymphoma.